The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

As Medicare turns 60, Medscape convened an expert panel to discuss the use of AI in medicine, physician reimbursement, and ...

As Medicare turns 60, Medscape convened an expert panel to discuss if physicians can survive without the program and the ways ...

As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark ...

Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...